Full Press Release Details
Hemophilia Therapy from Largest Multi-Year Donation Now Available to Patients in Developing World.
BIIB
Hemophilia Therapy from Largest Multi-Year Donation Now Available to Patients in Developing World
Key Takeaway: Hemophilia Therapy from Largest Multi-Year Donation Now Available to Patients in Developing World
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis